Purpose Body size, from birth throughout adulthood, is associated with breast cancer risk, but few studies have investigated early-life body size and benign breast disease (BBD), a well-established breast cancer risk factor. We consider whether prenatal factors and size at birth, 10, 18 year, and intervening growth, are related to BBD risk. Methods The Growing Up Today Study includes 9032 females who completed questionnaires annually from 1996 to 2001, then 2003, 2005, 2007, 2010, and 2013. In 1996, their mothers provided pregnancy-related data. From 2005 to 2013, participants (18 year?) reported whether they had ever been diagnosed with biopsy-confirmed BBD (N = 142 cases). Results Girls had greater adiposity (BMI; kg/m 2 ) at 10 year if they were larger at birth, if mother's prepregnancy BMI was higher, or if gestational weight gain was greater (all p \ .01). Maternal height was (positively) associated (p \ .05) with adolescent peak height growth velocity (PHV; in./year). Greater 10 year adiposity was associated with lower PHV and less height growth 10-18 year (both p \ .01). Adiposity at 10 year was inversely associated with BBD (OR 0.83/(kg/m 2 ), p \ .01) as was increasing adiposity 10-18 year (OR 0.85/(kg/m 2 ), p = .01). In a separate model, 10 year height (OR 1.13/in., p = .02) and height growth 10-18 year (OR 1.19/in.; p \ .01) were positively associated. PHV was similarly positively associated (OR 2.58, p = .01, fastest versus slowest growth quartiles). In a multivariable model of BBD risk, gestational weight gain (daughters at highest risk if \20 lb gained), PHV (slowest growing girls at lowest risk), age 10 year height (positive), and BMI (inverse) were the most critical childhood risk factors (each p \ .05). Conclusions Body size factors from pregnancy through adolescence were independently associated with BBD risk in young women.
Introduction
Substantial evidence implicates the period before the first full-term pregnancy, when mammary gland cells are undergoing rapid proliferation, as a critical time for exposures that may increase lifetime risk for breast cancer (BC) [1] . Some childhood and adolescent exposures are more important than adult exposures in BC development [2] [3] [4] [5] , so prevention efforts must begin early [6] . The hypothesis that BC may originate in utero [7] , when differentiation of offspring mammary glands is ongoing, has been supported by animal studies [8] . Both animal and human studies suggest mechanisms whereby in utero, childhood and adolescent exposures influence cancer risk in women [9] .
An impressive body of literature links high birth weight to increased risk of premenopausal BC [10] . Elevated BC risk has also been noted with higher birth length [11] . Maternal pre-pregnancy weight and gestational weight gain were not associated with BC in daughters [12] . A review article, acknowledging inconsistencies in the literature, concluded there is increased risk for females of lower gestational age, yet with greater birth weight and length [13] . However, after birth, the direction of the association changes, and by 5 year, body fatness is associated (independent of adult BMI) with lower risk of premenopausal and postmenopausal BC [14] . A recent investigation found that weight at 10 year and weight change to age 18 year were inversely related to lifetime risk [15] ; however, weight gains after 18 year were instead associated with higher lifetime risk. Other studies suggested that more rapid childhood height growth may be a factor in the development of cancer, especially BC [5, 16, 17] . One theory is that adiposity in girls might reduce BC risk by suppressing later height growth, thus reducing DNA damage or facilitating DNA repair [1] .
Because benign breast disease (BBD) is a well-established risk factor for BC [18] , the investigation of exposures in girls and their subsequent development of BBD may provide insight into the etiology of BC and present possible new strategies for prevention. A previous investigation of fetal and infant factors, in which nurses (aged 27-44) self-reported their own birth weights, found no association with proliferative BBD [19] . In a cohort of females born after 1980, with pregnancy data reported by their mothers, we similarly found no association between birth weight and BBD in young women [20] . However, girls whose mothers' pre-pregnancy BMI was below 20 kg/ m 2 , and girls whose mothers gained \20 lb during pregnancy, were at higher risk [20] . When these girls were age 9 years and older, higher BMI and less intense height growth spurt were linked to lower risk of BBD [21] .
This work has three purposes. First, parallel with a study of invasive BC [15] , we investigate the associations of 10 year body size, and change from 10 to 18 year, with biopsy-confirmed BBD in young women. Second, because we have data from very early life, we can simultaneously analyze factors from the prenatal period up to 18 year, in relation to BBD risk. Finally, by considering associations among these body size factors from different periods of life, we attempt to understand why childhood adiposity seems to protect against BBD and BC. The females in our cohort were born between 1980 and 1987, and disease follow-up is ongoing.
Materials and methods

Study population
The Growing Up Today Study (GUTS) includes 9032 girls from 50 states who are daughters of Nurses' Health Study II (NHSII) participants [22] . The study, approved by Institutional Review Boards at Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital, is described elsewhere [23] . Mothers provided informed consent, and their 9-to 15-year-old daughters assented by completing baseline questionnaires in 1996. The cohort returned questionnaires annually (mail or Internet) through 2001, then in 2003, 2005, 2007, 2010, and 2013 . The response rate to one or more follow-up after baseline was 97%. Over 81% returned at least one of the 2005 through 2013 surveys inquiring about BBD. At baseline, participants reported their race/ethnic group where 95% are white/non-Hispanic.
Benign breast disease
The 2005, 2007, 2010, and 2013 surveys inquired ''Has a health care provider ever diagnosed you as having Benign Breast Disease?'' and, if yes, whether it had been ''Confirmed by breast biopsy.'' A total of 7298 females (18-32 years) reported whether a health care provider ever diagnosed them with BBD (n = 334 said yes), and if any diagnosis had been confirmed by breast biopsy (n = 142). After excluding six girls whose mothers reported childhood cancer, 6958 females who returned surveys 2005-2013 but never reported BBD provide the non-cases for our BBD analyses.
Most BBD cases were likely diagnosed because participants (or physicians) found a clinically palpable mass, which was biopsied, since participants were too young for routine screening mammography. The most common type of BBD in adolescents and young women is fibroadenoma, accounting for nearly 70% of benign breast lesions; the remaining types are primarily cysts and fibrocystic changes [24] . A validation study in 621 NHSII women confirmed the accuracy (95%) of self-reported biopsy-confirmed BBD [25] .
Early-life factors: pre-pregnancy through birth
In 1996, mothers reported, for their daughters born during the previous decade, birth weight (pounds, ounces), birth length (in.), gestational age (full-term, 1-2 weeks early, 3-6 weeks early, ›6 weeks early), and height (feet, in.) of the biological father. Our 1999 survey to the mothers asked ''How much did you weigh before this pregnancy?'' and ''How much weight did you gain during this pregnancy?''
Regarding validity, recollections of 154 women's pregnancy-related events, from C30 years earlier, were compared to data collected at the time of their pregnancies [26] . Their recalls were highly accurate for pre-pregnancy weight (r = 0.86) and birth weight of their infants (r = 0.91). Another validation study [27] compared maternal reports (30 years later) of infants' birth weights with state birth records and found r = 0.85. Maternal recalls, 4-12 years after delivery, of weight gain during pregnancy agreed moderately well (r = 0.63) with the medical records [28] . Because our early-life data were recalled (9? years after childbirth) by mothers who were nurses, we expect a high degree of validity.
Factors from older childhood and adolescence
Height, weight, and adiposity
Children reported their heights and weights on each survey, beginning in 1996. Our questionnaire provided specific measuring instructions but suggested that they seek assistance; their own mothers self-reported their weights and height for NHSII [22] . An analysis of NHANES III adolescents indicated high validity for self-reported height (r = 0.82) and weight (r = 0.90) [29] . We assessed relative weight status by computing body mass index (BMI = weight/height 2 (kg/m 2 )). National Longitudinal Study of Adolescent Health analyses found high correlation (r = 0.92) between BMI computed from measured values and from self-reports of height and weight by youth in grades 7-12 [30] .
We obtained body height, weight, and BMI from surveys the girls returned when they were 10 year; if no survey was returned at age 10, we used the closest survey at 9 or 11 year; analyses adjusted for the exact age (months) when the survey was returned. We further assessed 10 year adiposity using the validated Stunkard body figure pictogram [31] , consisting of nine figures representing somatotype from thinnest to heaviest (see Fig. 1 in [14] ). The correlation between BMI and pictograms, both provided at 10 year, was r = 0.71, higher than in a validation study (r = 0.65) in which BMI's were measured in childhood but pictograms were recalled much later in adulthood [32] . Girls with 10-year data (N = 4455) are a subset of our full cohort because many were older at baseline (up to 15 year).
From later surveys, we obtained adult height, and (nonpregnant) weight and BMI at 18 year. Change in height, weight, and BMI from 10 to 18 year were computed as the 18 year measurement minus that obtained at 10 year, adjusted for exact (to the month) intervening time period.
The derivation of peak height growth velocity (PHV; in./year) was described earlier [21] . Because some girls were older at baseline (to 15 year), many had completed their height growth so we cannot estimate PHV from their annual heights, leaving us with 4999 girls with estimates of PHV and age when the growth spurt occurred (PKAGE). Our mean PHV of 3.22 in./year is comparable to means from several earlier cohorts that derived PHV from heights measured by study personnel [33] [34] [35] .
Other variables
We computed ages (to month) from dates of questionnaire return and birth. Our early surveys annually asked ''Have you started having menstrual periods?'' and ''If yes, age when periods began.'' Later surveys asked if the participants were, or had recently been, pregnant. Participants' mothers provided information regarding their own diagnoses of breast cancer and biopsy-confirmed BBD.
Statistical analyses
Logistic regression models provided odds ratios (OR) and 95% confidence intervals (CI) for biopsy-confirmed BBD [36] . Because age was related to each participant's chance of being diagnosed during follow-up, all models adjusted for age (to month) at cohort initiation. We first fit a series of models with body size exposures (BMI, height, or weight) at 10 year with change in same exposure size from 10 to 18 year. Because PHV is positively correlated with height growth from 10 to 18 years, another model related PHV to BBD risk. Finally, multivariable models included factors from very early life previously found to influence risk of BC (birth weight) or BBD (gestational weight gain, maternal pre-pregnancy BMI), along with body size and growth in older children. These models adjusted for maternal history of BC and BBD, and for multiple births and gestational age since they impact birth weight. Models were fit using continuous measures (e.g., height in in.), and other models used 3-level categorical versions of each continuous exposure to consider non-linear associations. Tests for trend (P t ) in categorized exposures were performed by using the median exposure value, within each category, as a continuous variable.
Because adiposity in girls is associated with lower risk of BBD and BC, we further used linear regression models to investigate how childhood adiposity affects subsequent growth, and similarly how the earliest (in utero and birth) factors affect body size at 10 year and subsequent growth.
Results
Over 81% of females returned at least one survey, from 2005 to 2013, containing BBD questions. Comparing early data of these participants with those who returned none, we found only very small differences. For example, included girls were slightly younger (5.8 weeks), but early-life factors (maternal pre-pregnancy BMI, gestational weight gain, and birth size) and 10 year body size (height, weight, BMI, pictogram) were similar for the included and missing females. The small age difference is unlikely to be a source of bias in our investigation of BBD risk factors. Table 1 presents the means or percents, within tertile of BMI at 10 year, of exposures and other important characteristics. Girls with higher 10 year BMIs had slower PHV and earlier menarche; though they were taller at 10 year, they had less total growth after 10 year, so that adult heights were similar. The thinnest 10-year olds were more likely to receive a BBD diagnosis (2.2%). Regarding family history, the thinnest 10-year olds tended to have fewer mothers with breast cancer (4.6%), but the heaviest 10-year olds had lowest maternal BBD rates (15.6%).
In BBD analyses parallel with a BC investigation [15] , adiposity at 10 year was inversely associated with BBD in young women (OR 0.83/(kg/m 2 ), p = .002) as was increase in adiposity from 10 to 18 year (OR 0.85/(kg/m 2 ), p = .01) ( Table 2 Model 1; both factors in model). In Model 2, 10 year weight (OR 0.84/(10 lbs); p = .04) was linked to lower risk, but subsequent weight change to 18 year was not (OR 0.96/(10 lbs); p = .58). Model 3 showed that 10 year height (OR 1.13/in., p = .02) and height growth from 10 to 18 year (OR 1.19/in.; p = .002) were associated with higher BBD risk. Total height growth from 10 year to adulthood is correlated (r = 0.37) with PHV, which is similarly associated with BBD (OR 2.58, To understand how these childhood body size factors interact, Table 3 shows that higher 10 year BMI is associated with lower PHV and with less height growth from 10 year to adulthood (both p \ .01). Age 10 BMI is also significantly associated with earlier menarche and earlier age at PHV, but it has no association with adult height. For body shape pictograms (rather than BMI) at 10 year, results are similar ( Table 3 ). The inverse associations between childhood adiposity (BMI and pictogram) and PHV are even stronger when analyzing BMI (or pictogram) two, or separately three, years before age at PHV (Table 3) . Adiposity immediately before peak growth (Table 3) is likely within the trajectory of the adolescent growth spurt and thus is, at least partly, a result of, rather than a cause, of growth velocity.
We further investigated early-life body size factors, to see their relation to body size at 10 year and subsequent growth (Table 4) . Girls had higher BMIs at 10 year if they were larger at birth (length, weight, BMI), if gestational weight gain was greater, or if mother's pre-pregnancy BMI was higher (all p B .01), but maternal and paternal height were not associated. Regarding PHV, only maternal height was (positively) associated (p \ .05). However, total height growth from 10 to 18 year was associated with many of the early-life factors and with parental heights (Table 4) . BMI change from 10 to 18 year was (positively) associated only with maternal pre-pregnancy BMI.
To simultaneously investigate body size factors from gestation throughout adolescence, and BBD risk, we put the key factors into a single multivariable model (Table 5 , Model 1). As reported previously [20] , mothers who gained C20 lb during pregnancy had daughters with significantly lower risk, and girls with the slowest PHV were also at significantly lower risk [21] (both factors were non-linearly associated with BBD). BMI at 10 year was inversely associated with risk (p \ .10). Birth weight had no association with BBD, nor did it modify associations with later adiposity (BMI at 10 year, BMI at 18 year) (not shown). Maternal pre-pregnancy BMI, which is moderately correlated with daughter's BMI at ages 10 year (r = 0.30) and 18 year (r = 0.35), was not significant. Further adjusting Model 1 for age 10 year physical activity did not materially affect any of the estimates (including age 10 year BMI), nor was physical activity itself associated with BBD [37] .
When we analyzed BMI at 18 year in place of BMI at age 10 (Model 2, Table 5 ), the significant non-linear associations of gestational weight gain and PHV persisted. When BMI at 18 year was then replaced by total height growth from 10 to 18 year (Model 3, Table 5 ), PHV was still significant (non-linear), while height growth from 10 to 18 year was not. In Model 4, both adult height (positive) and age 18 BMI (inverse) are significant risk factors for BBD, consistent with the BC literature.
Our final mutually adjusted model (Model 5, ; for weight at age 10 year, 70.5 and 95.5 lb; for weight change from ages 10-18 year, 42.9 and 65.8 lb; for height at age 10 year, 54.5 and 59.5 in., and height growth from 10 to 18 year 7.0 and 11.1 in.
Breast Cancer Res Treat (2017) 162:139-149 143 changes in BMI and in height from 10 to 18 year were no longer statistically significant, the other factors continued to be associated with BBD. We compared the top quartile to the bottom quartile of each factor, for age 10 year BMI OR 0.44 (p = .02), for 10 year height OR 3.14 (p = .04), for PHV OR 2.20 (p = .047), and for gestational weight gain OR 0.53 (p = .03) for [35 lb versus \20 lb. For the latter two factors, associations with BBD are non-linear. Even though greater adiposity at 10 year is associated with lower PHV (Table 3) , this model suggests that they are independent risk factors for BBD.
Discussion
In a prospective investigation of body size factors, BBD risk in young women was inversely related to 10 year BMI and weight, and with change in BMI from 10 to 18 year, while risk was positively related to age 10 year height, subsequent total height growth, and with PHV. Multivariable models, that included together body size factors from the prenatal period through adolescence, indicated that the inverse association of gestational weight gain [20] and the positive association of PHV [21] with BBD persisted, while the effect of maternal pre-pregnancy BMI [20] was diminished. In spite of strong evidence that birth weight is associated with BC [10] , we found no evidence that it is associated with BBD; in addition to investigating an intermediate disease outcome (BBD) rather than the final outcome (BC), our cohort was born more recently than women in studies of BC. Our multivariable analyses are important because there are many associations among factors from earliest life and through adolescence; higher birth weight (which increases BC risk [10] ) predicts greater risk of obesity in adolescence [38] , yet being heavier in childhood and adolescence is associated with lower risk for BBD [21] and BC [14] . Apparent inconsistencies such as these may reflect different pathways to disease. Other research (using mothers who in 2001 recalled information regarding their own pregnancies from 1946 to 1964) found a positive association between pre-pregnancy BMI and obesity in their daughters at age 18 year, and a U-shaped association between gestational weight gain and obesity in daughters [39] , both consistent with our data. Our finding that 10 year adiposity was inversely associated with PHV is consistent with work on a different cohort [33] , in which BMI at 5 year was inversely associated with PHV.
Our BBD findings are consistent with the only previous investigation of very early-life exposures [19] , in which The six factors of BMI and pictogram, at time points before PHV, appear only in models predicting subsequent PHV. Each predictor is in a separate regression model. Model N's range from 724 (models of adiposity 3 years before age at PHV) to 4999 (models using adiposity immediately before PHV) a Models predicting PHV adjust for age at PHV b Models adjust for exact age (to month) when age 10 adiposity (BMI or pictogram) was obtained. These dependent variables were only analyzed with predictor variables BMI and pictogram at age 10 year, as these are the only factors always measured earlier in time; for example, for many girls their BMI immediately before PHV was measured at age 11 year or later, and thus was not prior to growth from age 10 to 18 year Table 4 Linear regression models predicting adiposity, height growth, and development from age 10 throughout adolescence, from early life (prenatal through birth) body size factors women 27 year and older self-reported their own birth weight, and no association was found with proliferative BBD. Also consistent with our findings at 10 year, they reported a strong inverse association with 5 year childhood body fatness and BBD [19] . Furthermore, our BBD findings are consistent with studies suggesting that height growth during ages 8-14 year [16] , ages 4-7 and 11-15 year [17] , and PHV [5, 16] are associated with Included in the multivariable model, along with the six factors shown, are maternal breast cancer, maternal BBD, and girl's age at study initiation increased BC risk. Whether the most rapid growth itself, and how it may impact DNA damage and repair [1] , or related factors, such as dietary intakes or hormones that promote growth, are cancer initiators/promoters is unknown. The potential role and interplay between growth hormones, IGF-I and estrogen may suggest a biological mechanism; the liver is a major source of IGF-I; growth hormones provide the main stimulus for hepatic IGF-I production; and estrogen also impacts growth hormone secretion [40, 41] . Regarding genes, LIN28B influences childhood height growth, puberty and cancer progression [42] , and a variant near ADCY3-POMC is associated with increased childhood body mass index, reduced pubertal growth, and earlier puberty [42] . Interestingly, this is consistent with our findings since our girls with higher age 10 year BMI had lower PHV and earlier age at growth spurt and menarche.
Baer [14] discusses possible mechanisms for the lifetime protection against BC afforded by childhood adiposity. Although subsequent slower adolescent height growth may result in less DNA damage, lifetime protection from childhood adiposity may alternatively be through its influence on breast density [43, 44] . Alternatively, genes that are related to BMI trajectories, driven by changes in weight rather than height, during childhood and adolescence [45] , potentially could also be related to BC risk independent of effects on weight.
Mechanisms for the association we observed between gestational weight gain and risk of BBD are unclear, but studies by others may provide some insight. Among pregnant Swedish women, there was a significant association between progesterone level and gestational weight gain [46] . In a cross-sectional investigation of maternal and cord blood, mother's weight gain during pregnancy was associated with methylation (of IGF2 gene) patterns in maternal blood [47] , and these maternal patterns of methylation were associated with folate, B12, and methylation in cord blood. Thus, gestational weight gain likely has a number of pathways for impacting the child, including a common genetic susceptibility to adiposity [48] .
The longitudinal design of this investigation comprises its major strength. The earliest life exposure variables were reported by mothers as soon as 9 years after childbirth, long before the reporting of daughters' BBD, in our large cohort of girls from all over the US. Heights and weights of the girls, at 9 year and later, were reported in real time. Any misclassifications due to errors in reporting early-life factors or childhood height and weight are likely non-differential with respect to subsequent BBD, but may attenuate estimated associations between these factors and BBD. Although all models controlled for participant's age, and other potential confounders were included in multivariable-adjusted models, some residual and unmeasured confounding may remain. We cannot exclude the possibility of incomplete adjustment, or confounding through variables not considered, but little is known about childhood risk factors for BBD. Because our participants are all daughters of nurses, this reduces confounding by socioeconomic and other unmeasured factors, while enhancing the accuracy of the data. Although our cohort is not representative of US females, the comparison of risks within our cohort should still be valid and generalizable [49] . However, the racial/ethnic makeup of our cohort (95% white/non-Hispanic) hinders race/ethnic group-specific analyses and generalization to these other races/ethnicities.
In conclusion, we assessed the relationship between biopsy-confirmed BBD in young women and body size factors from very early life through adolescence, a period critical for the development of BC and other adult diseases. From girls born in the 1980s, we found evidence that four body size measures had strong independent associations with BBD; maternal gestational weight gain C20 lb produced daughters at lower risk, adiposity at 10 year was associated with lower risk, but 10 year height and peak adolescent height growth velocity were associated with increased risk. Continued follow-up of this cohort will be critical to re-assess these results as new cases of BBD, and eventually cases of BC, are diagnosed.
